CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING (2016)
3.4. PATENTS ANALYSIS
3.4.1. Patent analysis by year (2010-2016)
3.4.2. Patent analysis by region
3.5. PORTERS FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Technological advancements associated with MDC systems
3.6.1.2. Availability of improved and error-free MDC systems
3.6.1.3. Dearth of skilled professionals
3.6.2. Restraints
3.6.2.1. Laboratory budget constraints affect the procurement of MDC systems
3.6.2.2. Complex operability of latest liquid handling systems
3.6.3. Opportunities
3.6.3.1. Untapped potential of emerging markets
3.6.3.2. Development of miniaturized MDC systems
CHAPTER 4 MEDICAL DEVICE COATINGS MARKET, BY MATERIAL
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. METALS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.1. Silver
4.2.1.1. Market size and forecast
4.2.2. Titanium
4.2.2.1. Market size and forecast
4.2.3. Others
4.2.3.1. Market size and forecast
4.3. CERAMICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. POLYMERS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.1. Silicone
4.4.1.1. Market size and forecast
4.4.2. Parylene
4.4.2.1. Market size and forecast
4.4.3. Fluoropolymers
4.4.3.1. Market size and forecast
4.4.3.2. PTFE
4.4.3.2.1. Market size and forecast
4.4.3.3. PVDF
4.4.3.3.1. Market size and forecast
4.4.3.4. Others
4.4.3.4.1. Market size and forecast
CHAPTER 5 MEDICAL DEVICE COATINGS MARKET, BY COATING
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HYDROPHILIC COATING
5.2.1. Market size and forecast
5.3. HYDROPHOBIC COATING
5.3.1. Market size and forecast
CHAPTER 6 MEDICAL DEVICE COATINGS MARKET, BY DEVICE TYPE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. GENERAL SURGERY
6.2.1. Market size and forecast
6.3. CARDIOVASCULAR DEVICES
6.3.1. Market size and forecast
6.4. ORTHOPEDICS
6.4.1. Market size and forecast
6.5. DENTISTRY
6.5.1. Market size and forecast
6.6. NEUROLOGY
6.6.1. Market size and forecast
6.7. GYNECOLOGY
6.7.1. Market size and forecast
6.8. OTHER DEVICE TYPES
6.8.1. Market size and forecast
CHAPTER 7 MEDICAL DEVICE COATINGS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. ROYAL DSM
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. SURMODICS, INC
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.2.4. Key strategic moves and developments
8.3. COVALON TECHNOLOGIES LTD.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. HYDROMER, INC.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. PRECISION COATINGS CO., INC.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. AST PRODUCTS, INC.
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. ABBOTT LABORATORIES
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. BIOCOAT INC.,
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. SPECIALTY COATING SYSTEMS, INC.
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. HARLAND MEDICAL SYSTEMS, INC.
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments